Mode
Text Size
Log in / Sign up

Epicardial adipose tissue volume normalized to heart volume associated with obstructive coronary artery disease

Epicardial adipose tissue volume normalized to heart volume associated with obstructive coronary art…
Photo by Robina Weermeijer / Unsplash
Key Takeaway
Note the association between high epicardial adipose tissue volume and increased risk of obstructive coronary artery disease.

This cohort study analyzed 27,500 CT scans, comprising 25,155 individuals from the general population and 2,482 individuals from a clinical cohort with suspected coronary artery disease (CAD). The researchers investigated the optimal normalization procedure for epicardial adipose tissue volume (EATV) and its relationship to cardiac risk and obstructive CAD.

Results indicated that normalizing EATV to total heart volume (EATVh) was superior across all metrics and neutralized the effects of sex. In the population cohort, higher SCORE2 cardiac risk and higher prevalence of obstructive CAD increased across quartiles of EATVh. A positive association was observed between significantly higher EATVh and obstructive CAD in both the general and clinical cohorts.

A cut-off of 0.1 for EATVh demonstrated a negative predictive value (NPV) of 97.1% in the general population and 88.9% in the clinical cohort for obstructive CAD. No adverse events or safety data were reported.

While EATVh may serve as a useful marker for obstructive CAD in both symptomatic and asymptomatic patients, these findings are observational. The study reports associations between EATVh and CAD/SCORE2 risk rather than causal relationships.

Study Details

Study typeCohort
Sample sizen = 25,155
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Background: Increased epicardial adipose tissue volume (EATV) is a potentially important risk marker for coronary artery disease (CAD) available from cardiac computed tomography (CT) images. Sex-differences and effects of age and body size on EATV have been insufficiently explored, and no reliable reference values exist. Consequently, EATV has yet to find its deserved use in clinical practice. Objectives: To define normal values by sex and age, the best normalization procedure for EATV to neutralize effects of body-size, explore the relationship between normalized EATV and cardiac risk, and propose a clinically meaningful cut-off. Methods: AI-based automated EATV data from the general population (n=25,155) and a clinical cohort (n=2,482) with suspected CAD was normalized to height, BSA and heart volumes. Correlation between EATV and EAT attenuation was tested with Spearman?s rank correlation and linear regression to find the optimal normalization. Normalized EATV was compared to high-risk by SCORE2 and obstructive CAD in the population cohort. A cut-off including 95% of cases with obstructive CAD was defined in the general population and tested in the clinical cohort. Results: EATV varied with sex and age across cohorts. Normalization of EATV to total heart volume (EATVh) was superior by all metrics and neutralized the effects of sex. High-risk by SCORE2 and the prevalence of obstructive CAD increased over quartiles of EATVh in the population cohort, and significantly higher EATVh was seen with obstructive CAD in both cohorts. A cut-off of 0.1 in EATVh had a negative predictive value for obstructive CAD of 97.1% in the general population and 88.9% in the clinical cohort. Conclusions: EATV varies considerably with sex, age and body size. Normalization to heart volume outperformed other procedures, and EATVh is a useful marker of obstructive CAD in both the general population and symptomatic patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.